Varicella ACIP Vaccine Recommendations
Advisory Committee for Immunization Practices (ACIP)
ShareCompartir
On this Page
as Published in Morbidity and Mortality Weekly Report (MMWR)
The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).
CURRENT Varicella Vaccine Recommendations
- MMWR, July 19, 2013, Vol 62, #28
Updated Recommendations for Use of VariZIG — United States, 2013
Print version [20 pages] - MMWR, March 30, 2012, Vol 61, #12
FDA Approval of an Extended Period for Administering VariZIG for Postexposure Prophylaxis of Varicella
Print version [1.05MB, 30 pages] - MMWR, June 22, 2007, Vol 56, #RR-04
Prevention of Varicella: Recommendations of the ACIP
Print version [48 pages]
ARCHIVED Historical Varicella Immunization Publications
For your convenience, these archived publications can be used for historical and research purposes.
- MMWR, May 11, 2007, Vol 56, #18
Notice to Readers: Update on Supply of Vaccines Containing Varicella-Zoster Virus
Print version [28 pages] - MMWR, March 3, 2006, Vol 55, #8
A New Product (VariZIG™) for Postexposure Prophylaxis of Varicella Available Under an Investigational New Drug Application Expanded Access Protocol
Print version [28 pages] - MMWR, December 2, 2005, Vol 54, #47
Notice to Readers: Licensure of a Combined Live Attenuated Measles, Mumps, Rubella, and Varicella Vaccine
Print version [28 pages] - See also:
- MMRV recommendations
- Herpes Zoster recommendations
- Page last reviewed: November 21, 2014
- Page last updated: September 1, 2016
- Content source: